SUMMARY
ENTRAL catecholaminergic mechanisms have been implicated in the regulation of blood pressure. Haesler et al1) showed that intracerebroventricular administration of the neurotoxin 6-hydroxy dopamine to young spontaneously hypertensive rats (SHR) prevented the development of hypertension. This treatment caused marked and widespread depletion of brain norepinephrine (NE). In agreement with this finding, Bunag and Eferakeya2 observed that posterior hypothalamic lesions lowered blood pressure in SHR and renal hypertensive rats. Moreover, it was reported that microinjections of NE into the posterior hypothalamus increased systemic blood pressure of rats.3) From these observations, it is strongly suggested that abnormalities in noradrenergic transmission in the hypothalamus might have a role in the pathogenesis of hypertension.
The nucleus tractus solitarii in the medulla oblongata is also believed to have a crucial role in central cardiovascular regulation. Injection of catecholamines into this area results in a depression of systemic blood pressure.4) In contrast, bilateral lesions of the nucleus produce fulminating hypertension in rats.5) Thus, it seems likely that there might be regional differences in the role of norepinephrine in the central control of blood pressure.
The involvement of central dopaminergic pathways in the regulation of blood pressure and heart rate has been also well documented. Zandberg et al reported that the local injection of dopamine (DA) into the nucleus tractus solitarii decreased blood pressure.6) Le Fur et al7) and Chin et al8) have described an increase in the frontal cortical content of DA and an increase in the number of DA-binding sites in striatum and frontal cortex of SHR. Furthermore, in a clinical study, Kolloch et al9) reported that dopaminergic stimulation by bromocriptine reduced the sympathetic outflow and lowered blood pressure in patients with essential hypertension. This finding produced the hypothesis that reduced central dopaminergic activity might be a factor in the cause and maintenance of hypertersion.9)
In order to gain further insight into the relationship between central amine metabolism and hypertension, this study investigated alterations in the release of NE and DA in hypothalamic, medulla oblongata and striatal slices from spontaneously hypertensive rats. These studies document altered NE release from the hypothalamus and DA release from the striatum. of WKY (Table  I) proposed that the nigro-striatal dopaminergic system might have a role in elevating systemic blood pressure, because brain dopamine depletion by lesions in the substantia nigra attenuated the development of hypertension in SHR. Thus, the role of central dopamine in the regulation of blood pressure is still controversial, and further studies should be performed to evaluate the mechanisms of dopaminergic actions in the central nervous system of hypertension. In summary, the results of the present study show that stimulationevoked NE release was elevated in the hypothalamus, but unchanged in the medulla oblongata of SHR compared with age-matched WKY. In addition, the stimulation-evoked striatal DA release was significantly lower in SHR than in WKY. It is suggested that the enhanced noradrenergic activity in the hypothalamus and decreased dopaminergic activity in the striatum of SHR can produce an increased sympathetic outflow which could play a role in the pathogenesis of this form of hypertension.
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